Literature DB >> 8017356

Impaired esophageal emptying in reflux disease.

S Lin1, M Ke, J Xu, P J Kahrilas.   

Abstract

OBJECTIVES: The symptoms and mucosal damage that occur in gastroesophageal reflux disease (GERD) may be a consequence of either an increased frequency of reflux events or of a prolonged process of esophageal acid clearance. Acid clearance is dependent both upon effective esophageal emptying of luminal fluid and on normal salivary function to titrate residual acid to neutrality. This investigation examined the efficacy of esophageal emptying in a large group of GERD patients.
METHODS: Barium swallow examinations were done to categorize and quantify esophageal emptying dysfunction in 67 consecutive patients with reflux disease, compared with 85 patient asymptomatic controls. Quantitative fluoroscopic estimates of esophageal residua were compared with scintigraphic quantification in 14 controls and 20 GERD patients.
RESULTS: There was progressive impairment of esophageal emptying in the reflux patients without esophagitis compared with the controls, and it was even greater in patients with endoscopically evident esophagitis compared with reflux patients without esophagitis. Good correlation existed between the fluoroscopic and scintigraphic assessment of esophageal emptying.
CONCLUSIONS: These findings support the hypothesis that impaired esophageal emptying is an important determinant in the development of esophagitis among reflux patients. The dominant site of impaired emptying in the reflux patients was the phrenic ampulla as opposed to the tubular esophagus, suggesting a pathophysiological contribution of hiatus hernia.

Entities:  

Mesh:

Year:  1994        PMID: 8017356

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  11 in total

Review 1.  Management of the patient with incomplete response to PPI therapy.

Authors:  Peter J Kahrilas; Guy Boeckxstaens; Andre J P M Smout
Journal:  Best Pract Res Clin Gastroenterol       Date:  2013-06       Impact factor: 3.043

Review 2.  Symptom overlap and comorbidity of irritable bowel syndrome with other conditions.

Authors:  Christine L Frissora; Kenneth L Koch
Journal:  Curr Gastroenterol Rep       Date:  2005-08

Review 3.  Mechanisms of Barrett's oesophagus (clinical): LOS dysfunction, hiatal hernia, peristaltic defects.

Authors:  Sabine Roman; Peter J Kahrilas
Journal:  Best Pract Res Clin Gastroenterol       Date:  2014-11-12       Impact factor: 3.043

Review 4.  Expert consensus document: Advances in the physiological assessment and diagnosis of GERD.

Authors:  Edoardo Savarino; Albert J Bredenoord; Mark Fox; John E Pandolfino; Sabine Roman; C Prakash Gyawali
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-09-27       Impact factor: 46.802

5.  Cost effectiveness of competing strategies to prevent or treat GORD-related dysphagia.

Authors:  A Sonnenberg
Journal:  Pharmacoeconomics       Date:  2000-04       Impact factor: 4.981

6.  The relationship between gastroesophageal junction integrity and symptomatic fundoplication outcomes.

Authors:  Brexton Turner; Melissa Helm; Emily Hetzel; Max Schumm; Jon C Gould
Journal:  Surg Endosc       Date:  2019-06-18       Impact factor: 4.584

7.  Multivariate analysis of pathophysiological factors in reflux oesophagitis.

Authors:  G Cadiot; A Bruhat; D Rigaud; T Coste; A Vuagnat; Y Benyedder; T Vallot; D Le Guludec; M Mignon
Journal:  Gut       Date:  1997-02       Impact factor: 23.059

8.  Relevance of ineffective oesophageal motility during oesophageal acid clearance.

Authors:  M Simrén; J Silny; R Holloway; J Tack; J Janssens; D Sifrim
Journal:  Gut       Date:  2003-06       Impact factor: 23.059

9.  Manometric findings in patients with isolated distal gastroesophageal reflux.

Authors:  Yasemin Ozin; Ulku Dagli; Sedef Kuran; Burhan Sahin
Journal:  World J Gastroenterol       Date:  2009-11-21       Impact factor: 5.742

Review 10.  Emerging dilemmas in the diagnosis and management of gastroesophageal reflux disease.

Authors:  Peter Kahrilas; Rena Yadlapati; Sabine Roman
Journal:  F1000Res       Date:  2017-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.